Perspective Therapeutics, Inc. ( CATX) - Key Metrics
CATX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.51 | -$0.23 | -$0.18 |
| 2025Q3 | $0 | -$0.35 | -$0.22 | -$0.25 |
| 2025Q2 | $0 | -$0.30 | -$0.20 | -$0.26 |
| 2025Q1 | $0 | -$0.25 | -$0.30 | -$0.36 |
CATX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.35 |
| 2025Q3 | ? | -2.45 |
| 2025Q2 | ? | -2.83 |
| 2025Q1 | ? | -2.12 |
CATX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -8.87% | ? |
| 2025Q4 | -6.49% | ? |
| 2025Q3 | -7.17% | ? |
| 2025Q2 | -7.67% | ? |
| 2025Q1 | -17.02% | ? |
CATX
Price: $2.92
52 week price:
Earnings Per Share: -1.41 USD
Exchange: ASE
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 278.9 million